Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q1 FY24 results · Apr–Jun 2023
Metropolis Healthcare reported revenue from operations of ₹277.09 crore (down 1.0% from Q1 FY23) and net profit of ₹28.98 crore (down 13.7% from Q1 FY23) for Q1 FY24 (Apr–Jun 2023), on a consolidated basis.
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 277.09 | 279.86 | −1.0% | 282.55 | −1.9% |
| Other income | 3.05 | 3.04 | +0.4% | 1.23 | +148.9% |
| Total income | 280.14 | 282.90 | −1.0% | 283.77 | −1.3% |
| Profit before tax | 39.19 | 42.83 | −8.5% | 41.90 | −6.5% |
| Net profit for the period | 28.98 | 33.56 | −13.7% | 33.49 | −13.5% |
| Attributable to shareholders of the company | 28.80 | 33.40 | −13.8% | 33.36 | −13.7% |
| EPS, basic (₹) | 5.62 | 6.53 | −13.9% | 6.50 | −13.6% |
| Net margin (%) | 10.5 | 12.0 | 11.9 |
| Item | Q1 FY24 | Q1 FY23 | YoY | Q4 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 256.29 | 257.02 | −0.3% | 264.41 | −3.1% |
| Other income | 2.78 | 2.42 | +14.7% | 9.14 | −69.6% |
| Total income | 259.07 | 259.44 | −0.1% | 273.54 | −5.3% |
| Profit before tax | 35.23 | 35.58 | −1.0% | 48.32 | −27.1% |
| Net profit for the period | 26.13 | 28.38 | −7.9% | 39.93 | −34.6% |
| EPS, basic (₹) | 5.10 | 5.54 | −7.9% | 7.80 | −34.6% |
| Net margin (%) | 10.2 | 11.0 | 15.1 |
Consolidated
- Filed with BSE
- 03 Aug 2023, 16:17 IST
- Board meeting
- 02 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 03 Aug 2023, 16:17 IST
- Board meeting
- 02 Aug 2023
- Period
- 01 Apr 2023 to 30 Jun 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE